Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 25, 2020 - Issue 2
Submit an article Journal homepage
618
Views
12
CrossRef citations to date
0
Altmetric
Review

Emerging 5-HT receptor antagonists for the treatment of Schizophrenia

Mackenzie T. JonesMiller School of Medicine, University of Miami, Miami, FL, USAView further author information
,
Martin T. StrassnigMiller School of Medicine, University of Miami, Miami, FL, USAView further author information
&
Philip D. HarveyMiller School of Medicine, University of Miami, Miami, FL, USACorrespondence[email protected]
View further author information
Pages 189-200 | Received 22 Mar 2020, Accepted 21 May 2020, Published online: 08 Jun 2020

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Carlos A Larrauri, Philip D Harvey & John M Kane. (2023) A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 1: Addressing Daily Functioning and Cognitive Impairments Associated with Schizophrenia [Podcast]. Neuropsychiatric Disease and Treatment 19, pages 1331-1338.
Read now
Andrea de Bartolomeis, Mariateresa Ciccarelli, Licia Vellucci, Michele Fornaro, Felice Iasevoli & Annarita Barone. (2022) Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia. Expert Opinion on Pharmacotherapy 23:18, pages 2035-2052.
Read now

Articles from other publishers (10)

Dong Zhou, Tao Liu, Xinrui Rao, Xiaohua Jie, Yunshang Chen, Zilong Wu, Huilin Deng, Dan Zhang, Jian Wang & Gang Wu. (2023) Targeting diacylglycerol kinase α impairs lung tumorigenesis by inhibiting cyclin D3 . Thoracic Cancer 14:13, pages 1179-1191.
Crossref
Heng-Chang Zhang, Yang Du, Lei Chen, Zeng-Qiang Yuan & Yong Cheng. (2023) MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets. Neuroscience & Biobehavioral Reviews 146, pages 105064.
Crossref
F. A. Khaliullin, E. E. Klen, I. L. Nikitina, V. N. Pavlov, G. A. Rozit, G. G. Gaisina & A. V. Samorodov. (2023) Synthesis and Antidepressant Activity of Thietane-Containing 4-(2-oxo-2-phenylethyl)-1H-1,2,4-triazol-4-ium Bromides. Pharmaceutical Chemistry Journal 56:12, pages 1596-1603.
Crossref
Teresa Reynolds de Sousa, Correia DT & Filipa Novais. (2023) Exploring the Hypothesis of a Schizophrenia and Bipolar Disorder Continuum: Biological, Genetic and Pharmacologic Data. CNS & Neurological Disorders - Drug Targets 22:2, pages 161-171.
Crossref
Seenae Eum, Scot Kristian Hill & Jeffrey R Bishop. (2022) Considering medication exposure in genomic association studies of cognition in psychotic disorders. Pharmacogenomics 23:14, pages 791-806.
Crossref
John M. Kane. (2022) A New Treatment Paradigm. Journal of Clinical Psychopharmacology 42:5, pages S1-S13.
Crossref
Viacheslav Terevnikov & Grigori Joffe. (2022) Mirtazapine in schizophrenia – an undeservedly overlooked option?. International Clinical Psychopharmacology 37:4, pages 131-142.
Crossref
Qiongqiong Wu, Xiaoyi Wang, Ying Wang, Yu-Jun Long, Jing-Ping Zhao & Ren-Rong Wu. (2021) Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia. Neuroscience Bulletin 37:11, pages 1609-1624.
Crossref
Kunal Maini, Janice W. Hollier, Haley Gould, Victoria Bollich, John LaForge, Elyse M. Cornett, Amber N. Edinoff, Adam M. Kaye & Alan D. Kaye. (2021) Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia. Health Psychology Research 9:1.
Crossref
Steven M. Silverstein & Adriann Lai. (2021) The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update. Frontiers in Psychiatry 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.